Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lori Richards

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Midwifery & Women'S Health|February 5, 2010
How caregivers manage pain and distress in second-stage laborLinda Bergstrom, Lori Richards, Janice M Morse, et al.
Qualitative Health Research|June 27, 2009
Birth talk in second stage laborLinda Bergstrom, Lori Richards, Adele Proctor, et al.
SAGE Open Medicine|January 25, 2021
Risk assessment of preterm birth through identification and stratification of pregnancies using a real-time scoring algorithmLisa Be Shields, Clayton Weymouth, Kevin L Bramer, et al.
The Journal of Clinical Investigation|May 20, 2014
Targeting CD137 enhances the efficacy of cetuximabHolbrook E Kohrt, A Dimitrios Colevas, Roch Houot, et al.
The Journal of Clinical Investigation|June 4, 2019
Targeting CD137 enhances the efficacy of cetuximabHolbrook E Kohrt, A Dimitrios Colevas, Roch Houot, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Midwifery & Women'S Health|February 5, 2010
How caregivers manage pain and distress in second-stage laborLinda Bergstrom, Lori Richards, Janice M Morse, et al.
Qualitative Health Research|June 27, 2009
Birth talk in second stage laborLinda Bergstrom, Lori Richards, Adele Proctor, et al.
SAGE Open Medicine|January 25, 2021
Risk assessment of preterm birth through identification and stratification of pregnancies using a real-time scoring algorithmLisa Be Shields, Clayton Weymouth, Kevin L Bramer, et al.
The Journal of Clinical Investigation|May 20, 2014
Targeting CD137 enhances the efficacy of cetuximabHolbrook E Kohrt, A Dimitrios Colevas, Roch Houot, et al.
The Journal of Clinical Investigation|June 4, 2019
Targeting CD137 enhances the efficacy of cetuximabHolbrook E Kohrt, A Dimitrios Colevas, Roch Houot, et al.
Pageof 1